Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Change in Account Payables (2021 - 2025)

Lucid Diagnostics' Change in Account Payables history spans 5 years, with the latest figure at $220000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 107.55% year-over-year to $220000.0; the TTM value through Dec 2025 reached -$270000.0, down 381.25%, while the annual FY2025 figure was -$270000.0, 381.25% down from the prior year.
  • Change in Account Payables reached $220000.0 in Q4 2025 per LUCD's latest filing, up from -$82000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q1 2022 to a low of -$1.4 million in Q4 2021.
  • Average Change in Account Payables over 5 years is -$59750.0, with a median of -$26500.0 recorded in 2022.
  • Peak YoY movement for Change in Account Payables: skyrocketed 364.91% in 2023, then crashed 658.33% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$1.4 million in 2021, then soared by 96.06% to -$57000.0 in 2022, then surged by 364.91% to $151000.0 in 2023, then decreased by 29.8% to $106000.0 in 2024, then skyrocketed by 107.55% to $220000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Change in Account Payables are $220000.0 (Q4 2025), -$82000.0 (Q3 2025), and $4000.0 (Q2 2025).